Drug intelligence / Profile preview

1-deoxymannojirimycin

Development stage
Unknown
Modality
Small Molecules
01

Overview

**1-deoxymannojirimycin** is a small molecule inhibitor of class I α-mannosidase enzymes. It acts as a competitive and selective inhibitor of α-mannosidase I in the N-glycan processing pathway within the endoplasmic reticulum and Golgi apparatus. By inhibiting this enzyme's activity at nanomolar concentrations (IC50 ≈ 0.02 μM), it blocks the biosynthesis of complex-type oligosaccharides on glycoproteins and disrupts N-linked glycosylation[4][7][10]. This inhibition can induce ER stress in human cells[7]. The compound has demonstrated antiviral activity; derivatives have shown anti-HIV effects[1][2]. It is primarily used as an experimental tool in biochemical research to study glycoprotein processing and viral replication mechanisms.

Other names
D-manno-DeoxynojirimycinDeoxymannojirimycin3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5R)-(2R,3R,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol1-deoxy-mannojirimycin1-deoxynojirimycin (sometimes used interchangeably but is a related compound)LU-1LU1LU 1Antibiotic LU-11,5-Dideoxy-1,5-imino-D-mannitol
02

Targets

MAN1A1 (Endoplasmic reticulum α-1,2-mannosidase I)

Beyond the preview

Go deeper on 1-deoxymannojirimycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-deoxymannojirimycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call